Fig. 2: Anti-Tumor Effect of the Anti-CKAP4 Antibody in a Pancreatic Cancer Model (IMAGE)

Osaka University

Fig. 2: Anti-Tumor Effect of the Anti-CKAP4 Antibody in a Pancreatic Cancer Model

Caption

S2-CP8 pancreatic cancer cells were inoculated subcutaneously to generate a xenograft tumor. The intraperitoneal injection of either gemcitabine, a broad-spectrum antimetabolite and antitumor drug, or anti-CKAP4 antibody inhibited tumor growth. The combination of gemcitabine and anti-CKAP4 produced stronger effects.

Credit

Osaka University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.